The effect of the Bacille Calmette-Guérin (BCG) vaccine on the immunogenicity of separately administered serogroup C meningococcal vaccine and other vaccinations was examined in 28 infants randomized to receive BCG at age ≤7 days, at 3 months or after study completion. Immunogenicity of the serogroup C meningococcal vaccine and other routine vaccines might be improved when BCG is administered in early infancy.
Journal article
The Pediatric infectious disease journal
08/2024
43
809 - 812
From the Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Humans, Meningococcal Vaccines, BCG Vaccine, Antibodies, Bacterial, Vaccination, Infant, Infant, Newborn, Female, Male, Immunogenicity, Vaccine